ACHILLION PHARMACEUTICALS INC·4

Dec 14, 4:42 PM ET

Simon Nicholas 4

4 · ACHILLION PHARMACEUTICALS INC · Filed Dec 14, 2011

Insider Transaction Report

Form 4
Period: 2011-12-12
Simon Nicholas
Director10% Owner
Transactions
  • Award

    Stock Option (*Right to Buy)

    2011-12-12+20,00020,000 total
    Exercise: $7.59Exp: 2021-12-12Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The option grant vests as to 25% on the date of grant and as to an additional 2.08% at the end of each monthly period thereafter.

Documents

1 file
  • 4
    rrd328182.xmlPrimary

    SIMON FORM 4 ANNUAL GRANT